NCT01920594 - Study of GSK1278863 to Reduce Ischemic Events in Patients Undergoing Thoracic Aortic Aneurysm Repair | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

October 8, 2014

Study Completion Date

October 8, 2014

Conditions

Surgical Procedures

Interventions

DRUG

GSK1278863

White, round biconvex, film coated tablet with unit dose strength of 100 mg for oral administration

DRUG

Placebo

White, round biconvex, film coated GSK1278863 matching placebo tablet for oral administration

Trial Locations (15)

19104

GSK Investigational Site, Philadelphia

22908

GSK Investigational Site, Charlottesville

23298

GSK Investigational Site, Richmond

27710

GSK Investigational Site, Durham

30322

GSK Investigational Site, Atlanta

35233

GSK Investigational Site, Birmingham

44195

GSK Investigational Site, Cleveland

55905

GSK Investigational Site, Rochester

77030

GSK Investigational Site, Houston

80045

GSK Investigational Site, Aurora

90048

GSK Investigational Site, Los Angeles

308902

GSK Investigational Site, Pittsburgh

48109-5864

GSK Investigational Site, Ann Arbor

T2N 2T9

GSK Investigational Site, Calgary

G1V 4G5

GSK Investigational Site, Québec